The latest additions to the facility will be two freeze-drying machines, known as Lyophilisers, which are used in the anti-microbial manufacturing process. The upgraded site will also trial AI technology to optimise production processes.

According to the company, the upgrades will be operational by next year and at commercial manufacture in 2026, with a focus on manufacturing anti-microbials.

“A key strategic pillar of Pfizer’s product innovation work is our effort to help slow the spread of antimicrobial resistance, one of the biggest global health threats of our time,” Pfizer Australia Managing Director Anne Harris said.

The Mulgrave site is already producing and exporting medicines like cancer treatments, anaesthetics and anti-inflammatories to 60 countries, treating 15 million patients a year.

“The life-saving medicines manufactured in Melbourne are shipped all over the world, helping millions of people each year,” Husic said.

Husic recently played a hand in launching an “RNA blueprint” to ‘grow the local sector’, and his department has also developed a medical science co-investment plan to guide the government’s $1.5 billion medical manufacturing fund for “innovative therapeutics”.

Pfizer has been making heavy investments into Australia over the past few years, including the acquisition of companies that already exist in the domestic market.

This is because the Australian market is ‘hot’, as they say. So much so that Moderna also moved into Melbourne to build a state-of-the-art facility alongside their consumer rival.

But this new ‘health scare’ isn’t a ‘new COVID variant’.

Anti-microbial resistance (AMR), more commonly known as ‘superbugs’, are reportedly a ‘growing public health concern’, because ‘resistance makes infections harder to treat’.

10 million people will die from AMR by 2050 without intervention, according to the World Health Organisation, and Australia is right in the midst of a scare campaign at present.

‘Superbugs’ are ‘coming to get us all’, apparently. And only jabs can ‘save us’.

THE ‘SUPERBUG THREAT’

CSIRO has recently warned Aussies that superbugs are “one of the greatest threats facing humanity”, and Australia is at the frontline as one of the largest consumers of antibiotics.

The science agency has made AMR one of its new biopharma missions, and warns new drugs alone ‘will not be enough’ as ‘more resistance is built up over time’.

Authorities say they are testing for “dangerous antimicrobial resistant bacteria” in chicken, pork and beef from Australian supermarkets, amid concerns on the “spread of the bugs in the food supply”.

It comes as some have warned the secrecy over antibiotic usage on Australian farms risks damaging our international standing, as key trading partners drastically curb their own usage of the drugs.

They say we are heading into a ‘post-antibiotic era‘, where infections could ‘once again be deadly’.

Other journals have also concurred this is a massive danger to our society.

Just like we have seen time-and-time again, ‘experts’ are now racing to get a vaccine developed to combat this ’emerging worldwide threat’, raising even more red flags.